• Why We Need Clinical Trials For Lymphoma
  • Combo Therapy for CLL, Now in Phase 3 Study, Named Orphan Drug by FDA
  • Protein-Inhibiting Therapy May Reduce Stem-cell Transplant Complication GVHD
  • $42M European Initiative Aims to Improve Care for Blood Disorder Patients
  • Hormone Found to Hinder Success of Cord-Blood Transplants in Cancer Patients
  • Phase 2 Trial Begins of Combo Treatment for Certain B-Cell Lymphomas
  • Follicular Lymphoma Can Develop Along Two Paths, Study Shows
  • New CAR T-cell Therapy Shows ‘Remarkable’ Promise for Highly Refractory Lymphoma
  • Top 10 Lymphoma Articles of 2016
  • Proteins Mutated in Lymphoma Control Normal T-cell Development, Study Finds
  • Study Links 2 Inherited Mutations to Risk of Cutaneous T-Cell Lymphoma
  • Opdivo-Adcetris Combo Shows Promise in Heavily Treated Hodgkin Lymphoma Patients
  • Clinical Testing of T-Cell Therapy, JCAR017, for Diffuse Large B-cell Lymphomas Aided by FDA and EMA